About
Eckert & Ziegler SE is a prominent global provider of isotope technology, catering to the medical, scientific, and industrial sectors. Founded in 1997 and based in Berlin, Germany, the company is publicly listed on the TecDAX index. It operates through three main segments: Medical, Isotope Products, and Other. In the Medical segment, Eckert & Ziegler supplies pharmaceutical-quality radioactive ingredients for cancer treatment and diagnosis, including the Yttriga® product for yttrium-based therapies. The Isotope Products segment focuses on manufacturing and distributing radiation sources and standards for both medical and industrial applications. The company serves a diverse clientele, including healthcare providers, scientific research institutions, and industrial companies, primarily in Europe, North America, and Asia-Pacific. Eckert & Ziegler is committed to responsible business practices and adheres to legal and regulatory standards in all its operations. The company has experienced sales growth across various regions, particularly in North America and Asia-Pacific, and is recognized for its strong ESG risk management in the healthcare sector.
Technologies
Keywords
Company Information
-
Employees 170
-
Founded 1997
-
Annual Revenue $308959000
Location
10 Robert-Roessle-Strasse, Berlin, Berlin, Germany, 13125